Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × OTHER × Alpelisib × Clear all

Status

Completed 16 Active not recruiting 8 Terminated 6 Unknown 4 Recruiting 4 Withdrawn 2 No longer available 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Expanded_access 1

Sponsor

Conditions

Interventions

fludarabine phosphate 3 Amifampridine 3 gallium 68 PSMA-11 2 fludarabine 2 carbon-11 acetate 2 Magnetic Resonance Spectroscopy 2 Ga(III)-DOTATOC 2 Cyclophosphamide 2 3-Iodobenzylguanidine 2 veliparib 1 trametinib 1 selinexor 1 ponatinib 1 pembrolizumab 1 pegfilgrastim 1 omburtamab I-131 1 nirogacestat 1 ganitumab 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 elotuzumab 1 carfilzomib 1 asparaginase erwinia chrysanthemi recombinant 1 aldesleukin 1 Whole-Body Irradiation 1 Vorinostat 1 Vinorelbine 1 Trabectedin 1 Tacrolimus 1 TH 302 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03941782 2024-01-11

Compassionate Use of BYL 719 Alpelisib

New Mexico Cancer Research Alliance

No longer available

Lymphangioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡